NEW DELHI:Experts at India's drugs regulators have recommended for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute, the government said on Saturday.
A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge immunisation campaign in the world's second most populous country.
The government said the final decision on the two vaccines would be made by the chief of the Central Drugs Standards Control Organisation (CDSCO). That process is expected to be a formality given the urgency for a vaccine in the country with the highest number of COVID-19 infections in the world after the United States.
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council of Medical Research. Citing sources, Reuters reported on Friday that the shot could be approved, though little is known about the results of its clinical trials.
"Grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains," the government cited the experts' recommendation for COVAXIN, referring to the new strain of the virus first detected in Britain.
For the AstraZeneca/Oxford vaccine, the approval was "subject to multiple regulatory conditionalities", it said, without giving details.
Information and Broadcasting Minister Prakash Javadekar told reporters earlier that two other vaccines were waiting to be approved - Zydus Cadila's ZyCoV-D and Russia's Sputnik V that are both on trial in India.
"India is perhaps the only country where four vaccines are getting ready," he said.
"One was approved yesterday for emergency use, Serum's COVISHIELD." he said, referring to the fact that the AstraZeneca/Oxford shot is being made locally by the Serum Institute of India (SII).
The CDSCO is expected to announce the dosage and other details about the shot later. SII had applied for a two full-dose regime about 28 days apart.
AFFORDABLE VACCINE
The AstraZeneca/Oxford vaccine, which was granted its first approval by Britain on Tuesday, is cheaper and easier to use than some rival shots - major advantages in tackling a pandemic that has claimed more than 1.8 million lives worldwide.
However, it has been plagued by uncertainty about its most effective dosage ever since data published in November showed a half dose followed by a full dose had a 90% success rate while two full shots were 62% effective.
India's regulator has also received an emergency-use application for the COVID-19 vaccine made by Pfizer Inc with Germany's BioNTech - the first shot to secure regulatory approval in the West.
India has reported more than 10.3 million COVID-19 cases and around 150,000 deaths, though its rate of infection has come down significantly from a mid-September peak.
The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of this year.
SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses of the AstraZeneca/Oxford shot, which will be sold to the government at about 250 rupees ($3.42) per dose and 1,000 rupees on the private market.
Reuters
Sat Jan 02 2021
A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge immunisation campaign in the world's second most populous country. - Filepic
Shooting in Washington state leaves 5 dead; 15-year-old boy is in custody
The boy taken into custody was booked at the King County juvenile detention facility.
Malaysia to launch ASEAN Chairmanship 2025 logo and theme
Foreign Minister Datuk Seri Mohamad Hasan will launch the logo and theme during a ceremony at the Wisma Putra, in Putrajaya.
Ukraine blasts UN's Guterres over invitation to BRICS summit in Russia
The UN Secretary General declined Ukraine's invitation to the first Global Peace Summit in Switzerland, the ministry said.
Hospitals under fire as Israeli forces deepen operations in northern Gaza
Troops rounded up men and ordered women to leave the Jabalia historic refugee camp, residents and medics said.
Taiwan says live fire China drills may be part of a 'deterrence' effect
Taiwan's defence ministry said those exercises were part of routine Chinese training and it was keeping a close watch.
Bursa Malaysia's early gains erode as investors lock in profits
The benchmark index had initially opened 1.78 points firmer at 1,647.46.
Brazil's Lula says head injury 'serious,' with update from doctors in coming days
The president's injury forced him to cancel a trip to Russia for a summit of the BRICS group of major emerging markets being held in Kazan.
Blinken heads to Israel to revive Gaza ceasefire talks after Sinwar death
Blinken will focus discussions on how to end the war, plans for the enclave after the fighting ends and how to improve humanitarian assistance.
Facebook owner Meta restarts facial recognition tech in 'celeb-bait' crackdown
Meta said it will enroll about 50,000 public figures in a trial which involves automatically comparing their Facebook profile photos with images used in suspected scam advertisements.
BHP trying to avoid responsibility over Brazilian dam collapse, UK court told
More than 600,000 Brazilians, 46 local governments and around 2,000 businesses are suing BHP over the 2015 collapse of the Mariana dam in southeastern Brazil.
Minimum wage not benchmark for all employees' starting salaries - Sim
Steven Sim says the increase in the minimum wage is intended as a basic wage for workers with lower academic qualifications and skills.
Climate and China weigh on how the US views Pacific relations
Pacific leaders keep their preference for US President quiet, yet viewing relations only through the lens of China does nobody a service.
Gulen, the powerful cleric accused of orchestrating a Turkish coup, dies
Gulen was a one-time ally of Erdogan but they fell out spectacularly, and Erdogan held him responsible for the 2016 attempted coup.
[COLUMNIST] The reality of earthquakes in Malaysia: A threat we can’t ignore
The government needs to prepare the public to deal with such disasters in any way possible.
'PROTEGE-Veteran' provides job assurance for retirees
This is an aggressive step by the government to protect the welfare of retirees, said Dr Mohd Hasril Amiruddin.
US says THAAD anti-missile system is 'in place' in Israel
THAAD is a critical part of the US military's layered air defense systems and adds to Israel's already formidable anti-missile defenses.
IMAN Research calls for strengthening human security in 2025 Budget
IMAN Research identifies key areas for enhancement within the Malaysian government's Third MADANI Budget 2025.
Zambry assures academics of freedom of speech
Zambry says he is committed to preventing any actions that could infringe upon the rights and freedoms of academics across universities.
Media licensing framework development involves multiple consultations - Teo
Teo Nie Ching says the views of stakeholders have been considered through several engagement sessions and ongoing consultations.
ANALYSIS - World lags on 2030 nature goals headed into UN COP16 talks
A top concern for countries and companies is how to pay for conservation, with the COP16 talks aiming to develop new initiatives.